位置:首页 > 蛋白库 > FTSH_ECOLI
FTSH_ECOLI
ID   FTSH_ECOLI              Reviewed;         644 AA.
AC   P0AAI3; P28691; Q2M934;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   03-AUG-2022, entry version 137.
DE   RecName: Full=ATP-dependent zinc metalloprotease FtsH {ECO:0000255|HAMAP-Rule:MF_01458};
DE            EC=3.4.24.- {ECO:0000255|HAMAP-Rule:MF_01458};
DE   AltName: Full=Cell division protease FtsH;
GN   Name=ftsH {ECO:0000255|HAMAP-Rule:MF_01458};
GN   Synonyms=hflB, mrsC, std, tolZ; OrderedLocusNames=b3178, JW3145;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND MUTAGENESIS OF GLU-463 AND HIS-536.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8444796; DOI=10.1128/jb.175.5.1344-1351.1993;
RA   Tomoyasu T., Yuki T., Morimura S., Mori H., Yamanaka K., Niki H.,
RA   Hiraga S., Ogura T.;
RT   "The Escherichia coli FtsH protein is a prokaryotic member of a protein
RT   family of putative ATPases involved in membrane functions, cell cycle
RT   control, and gene expression.";
RL   J. Bacteriol. 175:1344-1351(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RA   Wang R., Kushner S.R.;
RT   "Identification and physical analysis of new genes in the argG region (69
RT   min) of Escherichia coli chromosome.";
RL   Submitted (SEP-1993) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8444797; DOI=10.1128/jb.175.5.1352-1357.1993;
RA   Tomoyasu T., Yamanaka K., Murata K., Suzaki T., Bouloc P., Kato A.,
RA   Niki H., Hiraga S., Ogura T.;
RT   "Topology and subcellular localization of FtsH protein in Escherichia
RT   coli.";
RL   J. Bacteriol. 175:1352-1357(1993).
RN   [6]
RP   DISCUSSION OF SEQUENCE.
RX   PubMed=1925026; DOI=10.1016/0923-2508(91)90041-8;
RA   Ogura T., Tomoyasu T., Yuki T., Morimura S., Begg K.J., Donachie W.D.,
RA   Mori H., Niki H., Hiraga S.;
RT   "Structure and function of the ftsH gene in Escherichia coli.";
RL   Res. Microbiol. 142:279-282(1991).
RN   [7]
RP   IDENTIFICATION OF HFLB AS FTSH.
RX   PubMed=8248182; DOI=10.1073/pnas.90.22.10861;
RA   Herman C., Ogura T., Tomoyasu T., Hiraga S., Akiyama Y., Ito K., Thomas R.,
RA   D'Ari R., Bouloc P.;
RT   "Cell growth and lambda phage development controlled by the same essential
RT   Escherichia coli gene, ftsH/hflB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:10861-10865(1993).
RN   [8]
RP   CHARACTERIZATION.
RX   PubMed=8106505; DOI=10.1016/s0021-9258(17)37678-0;
RA   Akiyama Y., Shirai Y., Ito K.;
RT   "Involvement of FtsH in protein assembly into and through the membrane. II.
RT   Dominant mutations affecting FtsH functions.";
RL   J. Biol. Chem. 269:5225-5229(1994).
RN   [9]
RP   FUNCTION, AND SIGMA-32 AS SUBSTRATE.
RX   PubMed=7781608; DOI=10.1002/j.1460-2075.1995.tb07253.x;
RA   Tomoyasu T., Gamer J., Bukau B., Kanemori M., Mori H., Rutman A.J.,
RA   Oppenheim A.B., Yura T., Yamanaka K., Niki H., Hiraga S., Ogura T.;
RT   "Escherichia coli FtsH is a membrane-bound, ATP-dependent protease which
RT   degrades the heat-shock transcription factor sigma 32.";
RL   EMBO J. 14:2551-2560(1995).
RN   [10]
RP   FUNCTION, AND SECY AS SUBSTRATE.
RX   PubMed=7753838; DOI=10.1073/pnas.92.10.4532;
RA   Kihara A., Akiyama Y., Ito K.;
RT   "FtsH is required for proteolytic elimination of uncomplexed forms of SecY,
RT   an essential protein translocase subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:4532-4536(1995).
RN   [11]
RP   INTERACTION WITH HFLC AND HFLK, AND SUBCELLULAR LOCATION.
RC   STRAIN=K12 / CSH26 / AD16;
RX   PubMed=8947034; DOI=10.1002/j.1460-2075.1996.tb01000.x;
RA   Kihara A., Akiyama Y., Ito K.;
RT   "A protease complex in the Escherichia coli plasma membrane: HflKC (HflA)
RT   forms a complex with FtsH (HflB), regulating its proteolytic activity
RT   against SecY.";
RL   EMBO J. 15:6122-6131(1996).
RN   [12]
RP   ACTIVITY REGULATION (MICROBIAL INFECTION), AND INTERACTION WITH HFLKC.
RC   STRAIN=K12 / CSH26 / AD16;
RX   PubMed=9159109; DOI=10.1073/pnas.94.11.5544;
RA   Kihara A., Akiyama Y., Ito K.;
RT   "Host regulation of lysogenic decision in bacteriophage lambda:
RT   transmembrane modulation of FtsH (HflB), the cII degrading protease, by
RT   HflKC (HflA).";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:5544-5549(1997).
RN   [13]
RP   CHARACTERIZATION.
RX   PubMed=9573051; DOI=10.1101/gad.12.9.1348;
RA   Herman C., Thevenet D., Bouloc P., Walker G.C., D'Ari R.;
RT   "Degradation of carboxy-terminal-tagged cytoplasmic proteins by the
RT   Escherichia coli protease HflB (FtsH).";
RL   Genes Dev. 12:1348-1355(1998).
RN   [14]
RP   MEMBRANE SUBSTRATES, AND INTERACTION WITH YCCA.
RC   STRAIN=K12 / CSH26 / AD16;
RX   PubMed=9636708; DOI=10.1006/jmbi.1998.1781;
RA   Kihara A., Akiyama Y., Ito K.;
RT   "Different pathways for protein degradation by the FtsH/HflKC membrane-
RT   embedded protease complex: an implication from the interference by a mutant
RT   form of a new substrate protein, YccA.";
RL   J. Mol. Biol. 279:175-188(1998).
RN   [15]
RP   MECHANISM OF MEMBRANE SUBSTRATE RECOGNITION.
RC   STRAIN=K12 / CSH26 / AD16;
RX   PubMed=10357810; DOI=10.1093/emboj/18.11.2970;
RA   Kihara A., Akiyama Y., Ito K.;
RT   "Dislocation of membrane proteins in FtsH-mediated proteolysis.";
RL   EMBO J. 18:2970-2981(1999).
RN   [16]
RP   MUTAGENESIS OF LEU-201; THR-297; ASN-298; ASP-304; LEU-307; ARG-309;
RP   ARG-312; GLU-415 AND HIS-418.
RX   PubMed=10473576; DOI=10.1074/jbc.274.37.26225;
RA   Karata K., Inagawa T., Wilkinson A.J., Tatsuta T., Ogura T.;
RT   "Dissecting the role of a conserved motif (the second region of homology)
RT   in the AAA family of ATPases. Site-directed mutagenesis of the ATP-
RT   dependent protease FtsH.";
RL   J. Biol. Chem. 274:26225-26232(1999).
RN   [17]
RP   LPXC AS SUBSTRATE, FUNCTION IN REGULATING LIPOPOLYSACCHARIDE SYNTHESIS, AND
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / W3110, and W2252;
RX   PubMed=10048027; DOI=10.1046/j.1365-2958.1999.01221.x;
RA   Ogura T., Inoue K., Tatsuta T., Suzaki T., Karata K., Young K., Su L.H.,
RA   Fierke C.A., Jackman J.E., Raetz C.R., Coleman J., Tomoyasu T.,
RA   Matsuzawa H.;
RT   "Balanced biosynthesis of major membrane components through regulated
RT   degradation of the committed enzyme of lipid A biosynthesis by the AAA
RT   protease FtsH (HflB) in Escherichia coli.";
RL   Mol. Microbiol. 31:833-844(1999).
RN   [18]
RP   RECOGNITION OF MEMBRANE SUBSTRATE FROM N-TERMINUS.
RX   PubMed=11256624; DOI=10.1093/embo-reports/kvd005;
RA   Chiba S., Akiyama Y., Mori H., Matsuo E., Ito K.;
RT   "Length recognition at the N-terminal tail for the initiation of FtsH-
RT   mediated proteolysis.";
RL   EMBO Rep. 1:47-52(2000).
RN   [19]
RP   ZINC-BINDING, AND MUTAGENESIS OF HIS-414; HIS-418; GLU-476 AND GLU-582.
RC   STRAIN=K12;
RX   PubMed=11827531; DOI=10.1021/bi015748o;
RA   Saikawa N., Ito K., Akiyama Y.;
RT   "Identification of glutamic acid 479 as the gluzincin coordinator of zinc
RT   in FtsH (HflB).";
RL   Biochemistry 41:1861-1868(2002).
RN   [20]
RP   RECOGNITION OF MEMBRANE SUBSTRATE FROM C-TERMINUS.
RC   STRAIN=K12 / JM103;
RX   PubMed=12169602; DOI=10.1128/jb.184.17.4775-4782.2002;
RA   Chiba S., Akiyama Y., Ito K.;
RT   "Membrane protein degradation by FtsH can be initiated from either end.";
RL   J. Bacteriol. 184:4775-4782(2002).
RN   [21]
RP   REQUIREMENT FOR ATP, AND MUTAGENESIS OF PHE-225 AND GLY-227.
RX   PubMed=14514680; DOI=10.1074/jbc.m308327200;
RA   Yamada-Inagawa T., Okuno T., Karata K., Yamanaka K., Ogura T.;
RT   "Conserved pore residues in the AAA protease FtsH are important for
RT   proteolysis and its coupling to ATP hydrolysis.";
RL   J. Biol. Chem. 278:50182-50187(2003).
RN   [22]
RP   TOPOLOGY [LARGE SCALE ANALYSIS], AND SUBCELLULAR LOCATION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15919996; DOI=10.1126/science.1109730;
RA   Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
RT   "Global topology analysis of the Escherichia coli inner membrane
RT   proteome.";
RL   Science 308:1321-1323(2005).
RN   [23]
RP   POSSIBLE INTERACTION WITH QMCA.
RC   STRAIN=K12;
RX   PubMed=16573693; DOI=10.1111/j.1365-2958.2006.05104.x;
RA   Chiba S., Ito K., Akiyama Y.;
RT   "The Escherichia coli plasma membrane contains two PHB (prohibitin
RT   homology) domain protein complexes of opposite orientations.";
RL   Mol. Microbiol. 60:448-457(2006).
RN   [24]
RP   INTERACTION WITH YIDC (OXAA).
RX   PubMed=18387365; DOI=10.1016/j.febslet.2008.02.082;
RA   van Bloois E., Dekker H.L., Froderberg L., Houben E.N., Urbanus M.L.,
RA   de Koster C.G., de Gier J.W., Luirink J.;
RT   "Detection of cross-links between FtsH, YidC, HflK/C suggests a linked role
RT   for these proteins in quality control upon insertion of bacterial inner
RT   membrane proteins.";
RL   FEBS Lett. 582:1419-1424(2008).
RN   [25]
RP   KDO TRANSFERASE (KDTA) AS SUBSTRATE, AND FUNCTION IN REGULATING
RP   LIPOPOLYSACCHARIDE BIOSYNTHESIS.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=18776015; DOI=10.1128/jb.00871-08;
RA   Katz C., Ron E.Z.;
RT   "Dual role of FtsH in regulating lipopolysaccharide biosynthesis in
RT   Escherichia coli.";
RL   J. Bacteriol. 190:7117-7122(2008).
RN   [26]
RP   RECEPTOR FOR CDI TOXIN ENTRY INTO TARGET CELL CYTOPLASM (MICROBIAL
RP   INFECTION), AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   PubMed=26305955; DOI=10.1073/pnas.1512124112;
RA   Willett J.L., Gucinski G.C., Fatherree J.P., Low D.A., Hayes C.S.;
RT   "Contact-dependent growth inhibition toxins exploit multiple independent
RT   cell-entry pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:11341-11346(2015).
RN   [27]
RP   PRELIMINARY CRYSTALLIZATION.
RX   PubMed=12037319; DOI=10.1107/s0907444902006972;
RA   Krzywda S., Brzozowski A.M., Karata K., Ogura T., Wilkinson A.J.;
RT   "Crystallization of the AAA domain of the ATP-dependent protease FtsH of
RT   Escherichia coli.";
RL   Acta Crystallogr. D 582:1066-1067(2002).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 141-395.
RX   PubMed=12176385; DOI=10.1016/s0969-2126(02)00806-7;
RA   Krzywda S., Brzozowski A.M., Verma C., Karata K., Ogura T., Wilkinson A.J.;
RT   "The crystal structure of the AAA domain of the ATP-dependent protease FtsH
RT   of Escherichia coli at 1.5 A resolution.";
RL   Structure 10:1073-1083(2002).
RN   [29]
RP   REVIEW.
RX   PubMed=19454621; DOI=10.1093/jb/mvp071;
RA   Akiyama Y.;
RT   "Quality control of cytoplasmic membrane proteins in Escherichia coli.";
RL   J. Biochem. 146:449-454(2009).
RN   [30]
RP   REVIEW.
RX   PubMed=19744556; DOI=10.1016/j.resmic.2009.08.011;
RA   Narberhaus F., Obrist M., Fuhrer F., Langklotz S.;
RT   "Degradation of cytoplasmic substrates by FtsH, a membrane-anchored
RT   protease with many talents.";
RL   Res. Microbiol. 160:652-659(2009).
CC   -!- FUNCTION: Acts as a processive, ATP-dependent zinc metallopeptidase for
CC       both cytoplasmic and membrane proteins. Plays a role in the quality
CC       control of integral membrane proteins. Degrades a few membrane proteins
CC       that have not been assembled into complexes such as SecY, F(0) ATPase
CC       subunit a and YccA, and also cytoplasmic proteins sigma-32, LpxC, KdtA
CC       and phage lambda cII protein among others. Degrades membrane proteins
CC       in a processive manner starting at either the N- or C-terminus;
CC       recognition requires a cytoplasmic tail of about 20 residues with no
CC       apparent sequence requirements. It presumably dislocates membrane-
CC       spanning and periplasmic segments of the protein into the cytoplasm to
CC       degrade them, this probably requires ATP. Degrades C-terminal-tagged
CC       cytoplasmic proteins which are tagged with an 11-amino-acid nonpolar
CC       destabilizing tail via a mechanism involving the 10SA (SsrA) stable
CC       RNA.
CC   -!- FUNCTION: As FtsH regulates the levels of both LpxC and KdtA it is
CC       required for synthesis of both the protein and lipid components of
CC       lipopolysaccharide (LPS). {ECO:0000269|PubMed:18776015}.
CC   -!- FUNCTION: (Microbial infection) Probably transports the toxic C-
CC       terminal region of CdiA from E.coli strain 536, E.cloacae strain ATCC
CC       13047 and of Y.pestis strain A across the inner membrane to the
CC       cytoplasm, where CdiA has a toxic effect. Toxin transport is strain-
CC       specific, mutations in this gene do not confer resistance to several
CC       other tested CdiA toxins. {ECO:0000269|PubMed:26305955}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit.;
CC   -!- ACTIVITY REGULATION: (Microbial infection) Activity against phage
CC       lambda cII protein is inhibited by EDTA but not by PMSF. In vitro pre-
CC       incubation of FtsH with HflKC abolishes its activity against phage
CC       lambda cII protein at the cytoplasmic side of the membrane.
CC       {ECO:0000269|PubMed:9159109}.
CC   -!- SUBUNIT: The E.coli AAA domain has been modeled as a homohexamer, in
CC       Thermus thermophilus the same domain crystallizes as a homohexamer.
CC       Forms a complex with HflKC (formerly called HflA); complex formation is
CC       stimulated by ATP. Interacts with YccA, and probably weakly with QmcA.
CC       Can be cross-linked to YidC (OxaA) and to a nascent polypeptide chain
CC       for an integral membrane protein. {ECO:0000269|PubMed:18387365,
CC       ECO:0000269|PubMed:8947034, ECO:0000269|PubMed:9159109,
CC       ECO:0000269|PubMed:9636708}.
CC   -!- INTERACTION:
CC       P0AAI3; P0ABC3: hflC; NbExp=9; IntAct=EBI-548381, EBI-551642;
CC       P0AAI3; P0ABC7: hflK; NbExp=7; IntAct=EBI-548381, EBI-558599;
CC       P0AAI3; P0AGB3: rpoH; NbExp=4; IntAct=EBI-548381, EBI-555342;
CC       P0AAI3; P03042: cII; Xeno; NbExp=5; IntAct=EBI-548381, EBI-4478343;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01458, ECO:0000269|PubMed:15919996, ECO:0000269|PubMed:8444797,
CC       ECO:0000269|PubMed:8947034}; Multi-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_01458, ECO:0000269|PubMed:15919996,
CC       ECO:0000269|PubMed:8444797, ECO:0000269|PubMed:8947034}.
CC   -!- DISRUPTION PHENOTYPE: Lethality, due to increased levels of LpxC, which
CC       increases the level of LPS in the cell and results in formation of
CC       abnormal membrane structures in the periplasm. Lethality is suppressed
CC       under conditions in which LPS synthesis is reduced (PubMed:10048027).
CC       Disruption confers resistance to cellular contact-dependent growth
CC       inhibition (CDI) CdiA of E.coli strain 536, E.cloacae strain ATCC 13047
CC       and of Y.pestis strain A, but not to CdiA from E.coli strain 93 toxin
CC       (PubMed:26305955). {ECO:0000269|PubMed:10048027,
CC       ECO:0000269|PubMed:26305955}.
CC   -!- MISCELLANEOUS: The ftsH gene was discovered independently through 3
CC       different phenotypes and received 3 different names: ftsH, for
CC       filamentous temperature-sensitive; tolZ, for colicin tolerance, and
CC       hlfB, because mutants show a high frequency of lysogenization when
CC       infected with phage lambda. {ECO:0000305|PubMed:19744556}.
CC   -!- MISCELLANEOUS: Requires ATP for protease catalytic activity, probably
CC       due to tight coupling of the 2 activities; ADP or non-hydrolyzable
CC       analogs cannot substitute, except when unfolded, non-physiological
CC       substrates are tested.
CC   -!- SIMILARITY: In the central section; belongs to the AAA ATPase family.
CC       {ECO:0000255|HAMAP-Rule:MF_01458}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the peptidase M41
CC       family. {ECO:0000255|HAMAP-Rule:MF_01458}.
CC   -!- CAUTION: Glu-476 was identified as the third Zn ligand
CC       (PubMed:11827531), however in other crystal structures (Aquifex
CC       aeolicus and Thermotoga maritima) the conserved equivalent residue does
CC       not bind Zn. Instead it makes a hydrogen bond with the side chain of
CC       the first catalytic Zn-binding residue and indirectly stabilizes the
CC       Zn. {ECO:0000305|PubMed:11827531}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA97508.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M83138; AAA23813.1; -; Genomic_DNA.
DR   EMBL; U01376; AAA97508.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U18997; AAA57979.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76210.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77222.1; -; Genomic_DNA.
DR   PIR; S35109; S35109.
DR   RefSeq; NP_417645.1; NC_000913.3.
DR   RefSeq; WP_001107467.1; NZ_STEB01000012.1.
DR   PDB; 1LV7; X-ray; 1.50 A; A=141-395.
DR   PDB; 4V0B; X-ray; 2.55 A; A/B/C=25-96.
DR   PDBsum; 1LV7; -.
DR   PDBsum; 4V0B; -.
DR   AlphaFoldDB; P0AAI3; -.
DR   SMR; P0AAI3; -.
DR   BioGRID; 4262980; 385.
DR   ComplexPortal; CPX-5046; FtsH-HflKC complex.
DR   DIP; DIP-35828N; -.
DR   IntAct; P0AAI3; 30.
DR   MINT; P0AAI3; -.
DR   STRING; 511145.b3178; -.
DR   MEROPS; M41.001; -.
DR   TCDB; 3.A.29.1.5; the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
DR   jPOST; P0AAI3; -.
DR   PaxDb; P0AAI3; -.
DR   PRIDE; P0AAI3; -.
DR   EnsemblBacteria; AAC76210; AAC76210; b3178.
DR   EnsemblBacteria; BAE77222; BAE77222; BAE77222.
DR   GeneID; 66672920; -.
DR   GeneID; 947690; -.
DR   KEGG; ecj:JW3145; -.
DR   KEGG; eco:b3178; -.
DR   PATRIC; fig|511145.12.peg.3271; -.
DR   EchoBASE; EB1469; -.
DR   eggNOG; COG0465; Bacteria.
DR   HOGENOM; CLU_000688_16_2_6; -.
DR   InParanoid; P0AAI3; -.
DR   OMA; QYGMTER; -.
DR   PhylomeDB; P0AAI3; -.
DR   BioCyc; EcoCyc:EG11506-MON; -.
DR   BioCyc; MetaCyc:EG11506-MON; -.
DR   BRENDA; 3.4.24.B17; 2026.
DR   BRENDA; 3.4.24.B20; 2026.
DR   SABIO-RK; P0AAI3; -.
DR   EvolutionaryTrace; P0AAI3; -.
DR   PRO; PR:P0AAI3; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISM:EcoCyc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098797; C:plasma membrane protein complex; IPI:ComplexPortal.
DR   GO; GO:0005524; F:ATP binding; ISM:EcoCyc.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0004176; F:ATP-dependent peptidase activity; IDA:EcoCyc.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IDA:EcoCyc.
DR   GO; GO:0008270; F:zinc ion binding; IDA:EcoCyc.
DR   GO; GO:0010466; P:negative regulation of peptidase activity; IDA:ComplexPortal.
DR   GO; GO:0030163; P:protein catabolic process; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; IDA:EcoCyc.
DR   Gene3D; 1.20.58.760; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   HAMAP; MF_01458; FtsH; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR041569; AAA_lid_3.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR005936; FtsH.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011546; Pept_M41_FtsH_extracell.
DR   InterPro; IPR000642; Peptidase_M41.
DR   InterPro; IPR037219; Peptidase_M41-like.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF17862; AAA_lid_3; 1.
DR   Pfam; PF06480; FtsH_ext; 1.
DR   Pfam; PF01434; Peptidase_M41; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF140990; SSF140990; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR01241; FtsH_fam; 1.
DR   PROSITE; PS00674; AAA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell inner membrane; Cell membrane; Hydrolase;
KW   Membrane; Metal-binding; Metalloprotease; Nucleotide-binding; Protease;
KW   Reference proteome; Transmembrane; Transmembrane helix; Zinc.
FT   CHAIN           1..644
FT                   /note="ATP-dependent zinc metalloprotease FtsH"
FT                   /id="PRO_0000084631"
FT   TOPO_DOM        1..4
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:8444797"
FT   TRANSMEM        5..25
FT                   /note="Helical"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        26..98
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:8444797"
FT   TRANSMEM        99..119
FT                   /note="Helical"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        120..644
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:15919996,
FT                   ECO:0000305|PubMed:8444797"
FT   REGION          598..644
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        415
FT                   /evidence="ECO:0000305"
FT   BINDING         192..199
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01458"
FT   BINDING         414
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000305"
FT   BINDING         418
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000305"
FT   BINDING         492
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01458"
FT   SITE            225
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         201
FT                   /note="L->N: No in vivo protease activity, no in vitro
FT                   ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         225
FT                   /note="F->A,D,E,G,N,Q,R,S,T: Does not complement ftsH1 at
FT                   42 degrees Celsius, no protease activity in vivo."
FT                   /evidence="ECO:0000269|PubMed:14514680"
FT   MUTAGEN         225
FT                   /note="F->C,H: Partially complements ftsH1 at 42 degrees
FT                   Celsius, some protease activity in vivo."
FT                   /evidence="ECO:0000269|PubMed:14514680"
FT   MUTAGEN         225
FT                   /note="F->I,L,M,V,W,Y: Complements ftsH1 at 42 degrees
FT                   Celsius, restores protease activity in vivo."
FT                   /evidence="ECO:0000269|PubMed:14514680"
FT   MUTAGEN         227
FT                   /note="G->A: Does not complement ftsH1 at 42 degrees
FT                   Celsius, no protease activity in vivo."
FT                   /evidence="ECO:0000269|PubMed:14514680"
FT   MUTAGEN         297
FT                   /note="T->A: Low protease activity in vivo, low ATPase
FT                   activity in vitro, complements ftsH1 at 42 degrees
FT                   Celsius."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         298
FT                   /note="N->A: No in vivo protease activity."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         304
FT                   /note="D->A,N: No in vivo protease activity, no in vitro
FT                   ATPase activity; probably still binds ATP."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         304
FT                   /note="D->E: Low protease activity in vivo, low ATPase
FT                   activity in vitro, complements ftsH1 at 42 degrees
FT                   Celsius."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         307
FT                   /note="L->A: Low protease activity in vivo."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         309
FT                   /note="R->A,L,K: No in vivo protease activity, no ATPase
FT                   activity in vitro; probably still binds ATP."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         312
FT                   /note="R->A,L,K: No in vivo protease activity, no ATPase
FT                   activity in vitro; probably still binds ATP."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         414..418
FT                   /note="HEAGH->KEAGK: Loss of protease function."
FT   MUTAGEN         414
FT                   /note="H->Y: Loss of protease function."
FT                   /evidence="ECO:0000269|PubMed:11827531"
FT   MUTAGEN         415
FT                   /note="E->Q: Loss of protease activity in vivo."
FT                   /evidence="ECO:0000269|PubMed:10473576"
FT   MUTAGEN         418
FT                   /note="H->Y: In tolZ21; loss of protease function in vivo,
FT                   retains about 25% ATPase activity, temperature sensitive."
FT                   /evidence="ECO:0000269|PubMed:10473576,
FT                   ECO:0000269|PubMed:11827531"
FT   MUTAGEN         463
FT                   /note="E->K: In ftsH1; a temperature-sensitive mutant which
FT                   increases the frequency of lysogenization of phage lambda;
FT                   when associated with A-587."
FT                   /evidence="ECO:0000269|PubMed:8444796"
FT   MUTAGEN         476
FT                   /note="E->D,K,V: Severe loss of protease function that is
FT                   restored by excess Zn."
FT                   /evidence="ECO:0000269|PubMed:11827531"
FT   MUTAGEN         476
FT                   /note="E->Q: Little effect on protease function."
FT                   /evidence="ECO:0000269|PubMed:11827531"
FT   MUTAGEN         536
FT                   /note="H->R: In hflB29; increases the frequency of
FT                   lysogenization of phage lambda."
FT                   /evidence="ECO:0000269|PubMed:8444796"
FT   MUTAGEN         582
FT                   /note="E->D,K,Q: No effect on protease function."
FT                   /evidence="ECO:0000269|PubMed:11827531"
FT   MUTAGEN         582
FT                   /note="E->V: Decreased protease function."
FT                   /evidence="ECO:0000269|PubMed:11827531"
FT   HELIX           34..42
FT                   /evidence="ECO:0007829|PDB:4V0B"
FT   STRAND          46..52
FT                   /evidence="ECO:0007829|PDB:4V0B"
FT   STRAND          55..60
FT                   /evidence="ECO:0007829|PDB:4V0B"
FT   STRAND          65..69
FT                   /evidence="ECO:0007829|PDB:4V0B"
FT   HELIX           77..83
FT                   /evidence="ECO:0007829|PDB:4V0B"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:4V0B"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           158..163
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           165..172
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           174..176
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   STRAND          187..191
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           198..209
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   STRAND          213..216
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           230..241
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   STRAND          245..250
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           253..256
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           270..283
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   STRAND          287..289
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   STRAND          291..298
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   TURN            300..302
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           305..308
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   STRAND          315..318
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           324..335
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           346..351
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           358..374
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   STRAND          378..380
FT                   /evidence="ECO:0007829|PDB:1LV7"
FT   HELIX           382..392
FT                   /evidence="ECO:0007829|PDB:1LV7"
SQ   SEQUENCE   644 AA;  70708 MW;  E24A753D8F486CA1 CRC64;
     MAKNLILWLV IAVVLMSVFQ SFGPSESNGR KVDYSTFLQE VNNDQVREAR INGREINVTK
     KDSNRYTTYI PVQDPKLLDN LLTKNVKVVG EPPEEPSLLA SIFISWFPML LLIGVWIFFM
     RQMQGGGGKG AMSFGKSKAR MLTEDQIKTT FADVAGCDEA KEEVAELVEY LREPSRFQKL
     GGKIPKGVLM VGPPGTGKTL LAKAIAGEAK VPFFTISGSD FVEMFVGVGA SRVRDMFEQA
     KKAAPCIIFI DEIDAVGRQR GAGLGGGHDE REQTLNQMLV EMDGFEGNEG IIVIAATNRP
     DVLDPALLRP GRFDRQVVVG LPDVRGREQI LKVHMRRVPL APDIDAAIIA RGTPGFSGAD
     LANLVNEAAL FAARGNKRVV SMVEFEKAKD KIMMGAERRS MVMTEAQKES TAYHEAGHAI
     IGRLVPEHDP VHKVTIIPRG RALGVTFFLP EGDAISASRQ KLESQISTLY GGRLAEEIIY
     GPEHVSTGAS NDIKVATNLA RNMVTQWGFS EKLGPLLYAE EEGEVFLGRS VAKAKHMSDE
     TARIIDQEVK ALIERNYNRA RQLLTDNMDI LHAMKDALMK YETIDAPQID DLMARRDVRP
     PAGWEEPGAS NNSGDNGSPK APRPVDEPRT PNPGNTMSEQ LGDK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025